New Zealand markets open in 9 hours 2 minutes

Maccura Biotechnology Co.Ltd (300463.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
13.43-0.25 (-1.83%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 8.38B
Enterprise value 8.13B
Trailing P/E 26.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.94
Price/book (mrq)1.29
Enterprise value/revenue 2.98
Enterprise value/EBITDA 12.42

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 3-18.52%
S&P500 52-week change 326.27%
52-week high 317.40
52-week low 39.90
50-day moving average 312.82
200-day moving average 314.22

Share statistics

Avg vol (3-month) 35.53M
Avg vol (10-day) 36.56M
Shares outstanding 5612.47M
Implied shares outstanding 6612.47M
Float 8366.09M
% held by insiders 138.83%
% held by institutions 15.90%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.35
Forward annual dividend yield 42.55%
Trailing annual dividend rate 30.16
Trailing annual dividend yield 31.13%
5-year average dividend yield 41.49
Payout ratio 467.10%
Dividend date 3N/A
Ex-dividend date 429 May 2023
Last split factor 230:10
Last split date 308 Jun 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 11.15%
Operating margin (ttm)22.19%

Management effectiveness

Return on assets (ttm)2.39%
Return on equity (ttm)4.66%

Income statement

Revenue (ttm)2.84B
Revenue per share (ttm)4.68
Quarterly revenue growth (yoy)-8.90%
Gross profit (ttm)N/A
EBITDA 617.04M
Net income avi to common (ttm)316.19M
Diluted EPS (ttm)0.52
Quarterly earnings growth (yoy)3.10%

Balance sheet

Total cash (mrq)959.7M
Total cash per share (mrq)1.58
Total debt (mrq)711.61M
Total debt/equity (mrq)10.60%
Current ratio (mrq)3.81
Book value per share (mrq)10.68

Cash flow statement

Operating cash flow (ttm)739.35M
Levered free cash flow (ttm)-389.97M